Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.

ClinicalTrials.gov ID: NCT00315848

Public ClinicalTrials.gov record NCT00315848. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 11:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Double-Blind, Parallel Group Study of the Safety and Efficacy of Buprenorphine Transdermal Delivery System Vs. Oxycodone/Acetaminophen Tablets Vs. Placebo in Patients With Chronic Pain Due to Osteoarthritis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to demonstrate the effectiveness and tolerability of the buprenorphine transdermal system (5, 10, and 20 mg) in comparison to placebo transdermal system and immediate release oxycodone/acetaminophen in subjects with osteoarthritis pain inadequately treated with non-opioid analgesics. The double-blind treatment intervention duration is 60 days.

Study identification

NCT ID
NCT00315848
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Purdue Pharma LP
Industry
Enrollment
225 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 1996
Primary completion
Not listed
Completion
Nov 30, 1999
Last update posted
May 2, 2006

1996 – 1999

United States locations

U.S. sites
10
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Rheumatology Associates of North Alabama Huntsville Alabama 35801
Arizona Research and Education Phoenix Arizona 85012
Phoenix Center for Clinical Research Phoenix Arizona 85015
Western Integrated Pain Treatment Centers Westminster Colorado 80030
Gainesville Clinical Research Center Gainesville Florida 32605
Park Place Therapeutic Center Plantation Florida 33324
MediSphere Medical Research Center, L.L.C. Evansville Indiana 47714
Stratton VA Medical Center Albany New York 12208
Metroplex Clinical Research Center Dallas Texas 75235
Arthritis Diagnostic and Treatment Center San Antonio Texas 78240

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Recently updated Osteoarthritis trials

Other public records listing Osteoarthritis. Sorted by last update posted; newest first. Not a recommendation.

All Osteoarthritis trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00315848, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 2, 2006 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00315848 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →